BALA CYNWYD, Pa., May 12, 2016 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Alexza
Pharmaceuticals, Inc. ("Alexza" or "the Company") (Nasdaq-
ALXA-News) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to Ferrer Pharma, Inc ("Ferrer Pharma").
Click here to learn more about the investigation
http://brodsky-smith.com/1072-alxa-alexza-pharmaceuticals-inc.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Alexza shareholders will
receive only $0.90 in cash for each
share of Alexza stock they own. In addition, Alexza shareholders
will receive one contingent value right entitling them to receive a
pro-rata share of up to four payment categories in an aggregate
maximum amount of $35 million.
However, the contingent value right payment is not guaranteed and
will only be paid if specified milestones are achieved. The
investigation concerns whether the Board of Alexza breached
their fiduciary duties to shareholders and whether Ferrer Pharma is
underpaying for the Company. The transaction may undervalue the
Company and would result in a substantial loss for many long-term
Alexza shareholders. For example, Alexza stock traded at
$5.00 per share on July 22, 2014 and an analyst has set a price
target on Alexza stock at $1.25 per
share.
If you own shares of Alexza stock and wish to discuss the legal
ramifications of the investigation, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L.
Brodsky, Esquire or Evan J. Smith,
Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
510, Bala Cynwyd, PA 19004,
by visiting
http://brodsky-smith.com/1072-alxa-alexza-pharmaceuticals-inc.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-alexza-pharmaceuticals-inc--alxa-300267965.html
SOURCE Brodsky & Smith, LLC